期刊文献+

PAK2真核表达载体的构建及在胃癌细胞内的表达与定位 被引量:1

Construction of the eukaryotic expressing vector of human PAK2 gene and the expression and location in gastric cancer cells
下载PDF
导出
摘要 目的构建PAK2真核表达载体及证实在胃癌细胞内的表达与定位。方法提取HeLa细胞的mRNA,反转录为cDNA。PCR扩增PAK2全长编码基因,克隆至pcDNA3.1A表达载体中。将构建的重组质粒测序并转染到胃癌细胞SGC-7901中,Western blot检测蛋白表达,免疫荧光检测PAK2在胃癌细胞内的定位。结果 hPAK2全长基因序列克隆到了真核表达载体pcDNA3.1A中,酶切鉴定片段为2 000 bp。Western blot检测到重组质粒蛋白表达,分子量约为75 kDa。免疫荧光检测pcDNA3.1A-PAK2在胃癌细胞内的定位以细胞浆为主,细胞核内少许。结论成功构建hPAK2全长基因真核表达载体,重组质粒主要定位于胃癌细胞浆。 Objective To construct an eukaryotic expressing vector of human PAK2 gene and identify its recombinant plasmid expression and location in the gastric cancer ceils. Methods Total mRNA was extracted from HeLa cells, cDNA was formed by reverse transcription.The PAK2 coding sequence was amplified by polymerase chain reaction (PCR)metbod and cloned into pcDNA3.1A vector. After the target region was sequenced, the plasmid was transfected into SGC-7901 cell lines. The expression of the pcDNA3.1A-PAK2 recombinant plasmid in SGC-7901 cells was proved by Western blot. The location of the plasmid in the cells was observed by using laser scanning confocal microscopy. Results hPAK2 was successfully constructed into pcDNA3.1A expressing vector. The length of the fragment was about 2000 bp, identified by restruction enzyme digestion. The expression of pcDNA3.1A-PAK2 recombinant plasmid in SGC-7901 cells was detecteded by Western blot, with a molecular weight of about 75 kDa.The plasmids were localized more in the cytoplasm, less in the nucleus. Conclusion The hPAK2 full length sequence was successfully cloned into eukaryotic expressing vector, the recombinant plasmids were localized mainly in the cytoplasm.
出处 《解剖学研究》 CAS 2011年第3期202-204,共3页 Anatomy Research
基金 国家自然科学基金重大研究计划(90813038) 国家自然科学基金(30771128 31000627)
关键词 PAK2 真核表达 免疫印记 免疫荧光 胃癌 PAK2 Eukaryotic expression Western blot Immunofluorescence Stomach neoplasms
  • 相关文献

参考文献10

  • 1Kumar R, Gururai AE, Barnes CJ, et al. p21-activated kinases in cancer. Nat Rev Cancer, 2006, 6(6) : 459-471.
  • 2Manser E, Leung T, Salihuddin H, et al. A brain serine/ threonine protein kinase activated by Cdc42 and Racl. Nature, 1994,367(6458) :40-46.
  • 3Manser E, Chong C, Zhao Z. S,et al. Molecular cloning of a new member of the p21-Cdc42/Rac-activated kinase (PAK) family. J Biol Chem, 1995,270 (42): 25070- 25078.
  • 4Teo M, Manser E, Lim L. Identification and molecular cloning of a p21cdc42/racl-activated serine/threonine kinase that is rapidly activated by thrombin in platelets. J Biol Chem, 1995, 270(44) : 26690-26697.
  • 5Widmann C, Gibson S, Johnson GL. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem, 1998, 273(12) :7141-7147.
  • 6Jakobi R, Moertl E, Koeppel MA. p21-activated protein kinase gamma-PAK suppresses programmed cell death of BALB3T3 fibroblasts. J Biol Chem, 2001,276 (20): 16624-16634.
  • 7Chew TL, Masaracchia RA, Goeckeler ZM, et al. Phosphorylation of non-muscle myosin Ⅱ regulatory light chain by p21-activated kinase (gamma-PAK). J Muscle Res Cell Motil, 1998, 19(8) : 839-854.
  • 8Li T, Zhang J, Zhu F, et al. P21-activated protein kinase (PAK2)-mediated c-Jun phosphorylation at 5 threonine sites promotes cell transformation. Carcinogenesis, 2011,32 (5) : 659-666.
  • 9Siu MK, Wong ES, Chan HY, et al.Differential expression and phosphorylation of Pakl and Pak2 in ovarian cancer: effects on prognosis and cell invasion. Int J Cancer, 2010, 127(1):21-31.
  • 10Li X, Liu F, Li F. PAK as a therapeutic target in gastric cancer. Expert Opin Ther Targets, 2010, 14(4) :419-433.

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部